« Back to Medicines list

JETREA 0.375mg/0.3mL solution for injection

  • Name:

    JETREA 0.375mg/0.3mL solution for injection

  • Company:
    info
  • Active Ingredients:

    Ocriplasmin

  • Legal Category:

    Product subject to restricted prescription (C)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 11/03/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 11/3/2019

Click on this link to Download PDF directly

Oxurion N.V.

Company Products

Medicine NameActive Ingredients
Medicine Name JETREA 0.375mg/0.3mL solution for injection Active Ingredients Ocriplasmin
1 - 0 of 1 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 30 August 2019 Ed-Ptnt

Reasons for updating

  • Replace document

Updated on 22 August 2019 Ed-Ptnt

Reasons for updating

  • Replace document

Updated on 1 August 2019 Ed-Ptnt

Reasons for updating

  • Add New Doc

Updated on 1 August 2019 Ed-HCP

Reasons for updating

  • Add New Doc

Updated on 1 August 2019 Ed-Ptnt

Reasons for updating

  • Add New Doc

Updated on 11 March 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 11 March 2019 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to restricted prescription (C)

Updated on 23 October 2018 PIL

Reasons for updating

  • Company name change or merger

Updated on 18 October 2018 SmPC

Reasons for updating

  • Company name change or merger

Legal category: Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

Type IA (in) variation to EMA (Company Name Change, September 17th 2018)

Updated on 12 July 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to restricted prescription (C)

Updated on 12 July 2018 PIL

Reasons for updating

  • New PIL for new product

  • Jetrea 0.375mg/0.3 mL solution for Injection Direct HealthCare Professional CommunicationRisk Minimisation Materials

    files-icon(Click to Download)

  • Jetrea 0.375mg/0.3 mL solution for Injection Patient LeafletRisk Minimisation Materials

    files-icon(Click to Download)

  • Jetrea 0.375mg/0.3 mL solution for Injection Patient BookletInstructions for use

    files-icon(Click to Download)